Endometrial Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cadonilimab (AK104) in combination with lenvatinib for advanced endometrial cancer; the study is currently…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]
Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706-based therapy in advanced endometrial cancer patients who progressed after PD-1/PD-L1 therapy; curr…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer [Phase 2]
A Phase 2 clinical trial investigating radiation therapy with Paclitaxel and Carboplatin in high-risk endometrial cancer was terminated; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pembro/Carbo/Taxol in Endometrial Cancer [Phase 2]
Phase 2 trial investigating pembrolizumab, carboplatin, and paclitaxel in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma [Phase 2]
Phase 2 clinical trial update on megestrol acetate with metformin in endometrial atypical hyperplasia and early-stage endometrial adenocarci…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel and carboplatin with or without metformin in advanced or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with recurrent or metastatic endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. [Phase 2]
Phase 2 clinical trial evaluating Oncoxin-Viusid in cervical cancer and endometrial adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines [Phase 4]
Phase 4 clinical trial comparing wound infiltration with ketamine versus dexmedetomidine added to bupivacaine and its effect on cytokines in…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial assessing trastuzumab in stage III/IV or recurrent endometrial cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating three regimens for endometrial cancer: paclitaxel-carboplatin-bevacizumab, paclitaxel-carboplatin-temsirolimus, and…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in patients with recurrent or persistent endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial of trebananib for persistent or recurrent endometrial cancer has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer [Phase 2]
Phase 2 trial evaluating MK2206, an Akt inhibitor, in recurrent or advanced endometrial cancer; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate for recurrent or persistent endometrial cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial update of ixabepilone in patients with recurrent or persistent endometrial cancer; completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluated temsirolimus in patients with metastatic or locally advanced recurrent endometrial cancer, with results p…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [Phase 1]
Phase 1 trial evaluating the safety of combining chemotherapy with radiation therapy for stage III or stage IV endometrial cancer has comple…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus [Phase 2]
A Phase 2 clinical trial evaluated medroxyprogesterone acetate for treating endometrial cancers, including endometrial adenocarcinoma and re…